New combination therapy of registered drugs shortens anti-Wolbachia therapy

(Liverpool School of Tropical Medicine) Researchers from LSTM's Research Centre for Drugs and Diagnostics have found a way of significantly reducing the treatment required for lymphatic filariasis and onchocerciasis from several weeks to seven days. By targeting Wolbachia, a bacterial symbiont that the filarial parasites need to live, the team has discovered a drug synergy that enables effective treatment over a shorter time.
Source: EurekAlert! - Biology - Category: Biology Source Type: news